Yearn for food and cigarette are two unhealthy urges, which can lead you to path of inheriting various diseases. Detrimental habits like these if not restricted on time, they can lead you to disastrous consequences. Medical science has found a medication, Acomplia (Rimonabant) to manage both food and cigarette yearnings.
Acomplia works by targeting the CBI receptors and blocking the body's ability to receive signals that tells it to smoke or eat more. It helps to normalize the EC system thus making hunger and cigarette cravings more manageable. This blocking of signals is consequential in weight loss. In addition to this, it also improves the cardiovascular or metabolic risk factors in obese people and trim downs their dependence on tobacco and helps them quit smoking.
Although acomplia benefits more of the obese people, still it's usefulness for the community of smokers cannot be left unnoticed. Its trial has confirmed that it is an effective way to relinquish smoking too.
Studies on Acomplia have reflected a few side-effects, which can be enlisted as -:
&bullIrritability
&bullRestlessness
&bullNausea
&bullDizziness
&bullDepression
The are fewer as compared to other drugs. Its positive effects on weight loss, smoking cessation, and its aptitude to maintain a healthy cholesterol level, blood sugar and blood pressure are highly beneficial for the consumers.
Though is one of the most promising weight loss drugs, it still should not be taken without the consultation of a doctor. No one can better advise you on the drug than your physician. He may not allow you to take acomplia if you have had some serious health problems in the past.
Take the medication as per the medical directions. Some people have the misconception that if they double the dose than that actually prescribed, they can get better results. It is not true. Do not attempt to double the dose as it can prove to be harmful for your health. Precautionary measures should be taken while consuming Acomplia medication for effective weight loss.
The medical community eagerly awaits the FDA approval of Acomplia. The scientific name for . Developed by the French drug maker Sanofi-Aventis, it is contemplated to be launched under the name 'Zimulti' in the US.
Summary
Medical science has found a medication which is beneficial to control both food and cigarette yearnings. This will help people to lose weight and quit smoking and will also curb certain other unhealthy habits. The dual character of acomplia distinguishes it from other weight reducing drugs. It is a promising drug, one of the most significant drugs ever made to cater to the grave needs of people.
